VBI Vaccines Inc. Share Price Toronto S.E.
Equities
VBV
CA91822J1030
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.82 CAD | -5.12% | -7.66% | -10.58% |
16/04 | VBI Vaccines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
15/04 | North American Morning Briefing : Stock Futures -2- | DJ |
Sales 2024 * | 1.45Cr 1.98Cr 120.91Cr | Sales 2025 * | 3.41Cr 4.67Cr 284.9Cr | Capitalization | 1.81Cr 2.48Cr 151.47Cr |
---|---|---|---|---|---|
Net income 2024 * | -4.2Cr -5.74Cr -350.67Cr | Net income 2025 * | -2.5Cr -3.42Cr -208.73Cr | EV / Sales 2024 * | 1.25 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.53 x |
P/E ratio 2024 * |
-0.46
x | P/E ratio 2025 * |
-1.24
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.01% |
1 day | -5.12% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Baxter
CEO | Chief Executive Officer | 62 | 01/16/01 |
Nell Beattie
DFI | Director of Finance/CFO | 36 | 09/15/09 |
David Anderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 06/16/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 24/23/24 |
Steven Gillis
CHM | Chairman | 71 | 01/05/01 |
Jeff Baxter
CEO | Chief Executive Officer | 62 | 01/16/01 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.37% | 4.82TCr | |
-1.01% | 4.17TCr | |
+42.10% | 4.1TCr | |
-5.31% | 2.88TCr | |
+9.34% | 2.56TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.29TCr | |
+26.99% | 1.2TCr | |
-3.38% | 1.18TCr |
- Stock Market
- Equities
- VBIV Stock
- VBV Stock